Metrics

  • citations in SCIndeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[]
  • visits in previous 30 days:9
  • full-text downloads in 30 days:7

Contents

article: 6 from 32  
Back back to result list
2019, vol. 25, iss. 3-4, pp. 81-94
Measles outbreak in Kraljevo, Serbia 2017/2018
aDom zdravlja, Kraljevo
bZavod za javno zdravlje, Kraljevo

emaillesta59@yahoo.com
Keywords: disease outbreak; immunization; elimination; recommendations
Abstract
Introduction: Measles is a very contagious, infectious disease. It is a humongous health problem all over the world. It is an endemic disease in 14 Europian countries, including Serbia. Objective: Review of epidemiologic characteristics of a measles epidemic in relation to age, gender, vaccination status, complications and hospitalizations of the diseased in Kraljevo area. Method: Retrospective epidemiologic study of the individual illness reports, official reports of the Public health institute and Primary Health care Center, Kraljevo. Results: During the period from October, 30th 2017 to March 27th, 2017, 243 persons fell ill with measles of whom 135 (56%) were women, and 108 (44%) were men (p=0,127). The first two cases were reported on October, 30th 2017. after they've been in contact with the diseased persons in Pristina. The outbreak peak was in Decembre, 2017. The majority of the diseased were aged 30-49, 147 (60.5%). The illness was confirmed in the lab, in 15 persons. 30 (12.3%) people received two vaccine doses, while the rest were either incompletely vaccinated or of the unknown vaccination status. Complications appeared in 48 patients, and it was statistically significant in the age group 1-4 (p=0.0004). Complications were pneumonia 12.3%, diarrhea 6.6%, otitis media 1.6%. There were no death outcomes during the measles outbreak in Kraljevo. There were 40 (16.5%) diseased health workers and other health personnel. Conclusion: Immunization with two vaccine doses, which would include at least 95% of the general population, is the only effective preventive measure against measles. All the suspicious disease cases should be recognized, detected, reported and investigated in order to disrupt the viral breach, as soon as possible. It is necessary to undertake the anti-epidemic measures and enable adequate cooperation between general physicians (GPs) and epidemiologists.
References
*** (2015) M-M-R® II (Measles, mumps, and rubella virus vaccine live). Kenilworth, NJ: Merck & Co, revised October
*** Mere sprečavanja širenja virusa morbila u zdravstvenim ustanovama. Available from: http://www.batut.org.rs/download/reZaSprecavanjeSirenjaVirusaMorbilaUZU.pdf [accessed 2019 January 27]
Božić, M., Dokić, Lj., Nikolić, S., Pavlović, M., Šašić, M. (2009) Infektivne bolesti - udžbenik za studente medicine. Beograd: Medicinski fakultet Univerziteta u Beogradu-CIBID
Coughlin, M.M., Beck, A.S., Bankamp, B., Rota, P. (2017) Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies. Viruses, 9(1): 11-11
Čalkić, L., Skomorac, M., Tandir, S., Sivić, S., Bajramović-Omeragić, L. (2018) Public health significance of immunization and epidemic occurrence of measles. Med Glas (Zenica), 15(1): 46-51
Đurić-Petković, D., Ristanović, E., Kuljić-Kapulica, N. (2017) Virus malih boginja. MD - Medical data, vol. 9, br. 3, str. 181-184
European Centre for Disease Prevention and Control (ECDC) (2018) Risk of measles transmission in the EU/EEA. Stockholm, 21 March 2018. Available from: https://ecdc.europa.eu/en/publications-data/rapidriskassessment-risk-measles-transmissioneueea [accessed 2019 January 27]
European Centre for Disease Prevention and Control (ECDC) (2018) Monthly measles and rubella monitoring report: January 2019. Stockholm, Available from: https://ecdc.europa.eu/en/measles [accessed 2019 January 27]
European Centre for Disease Prevention and Control (ECDC) Case Definition: Measles. Stockholm, EUVAC net. Available from:https://ecdc.europa.eu/en/surveillance-and -disease-data/eu-casedefinition [accessed 2019 January 27]
Institute of Public Health of Serbia (2018) The current epidemiological situation of measles in the Republic of Serbia. Available from: http://www.batut.org.rs/index.php?content=1629 [accessed 2019 January 25]
Ministarstvo zdravlja Republike Srbije (2016) Zakon o zaštiti stanovnika od zaraznih bolesti. Sl. glasnik RS, br 15
Ministarstvo zdravlja Republike Srbije (2017) Pravilnik o prijavljivanju zaraznih bolesti i posebnih zdravstvenih pitanja. Sl. glasnik RS, br 44
Ministarstvo zdravlja Republike Srbije (2016) Uredba o programu zdravstvene zaštite stanovništva od zaraznih bolesti. Sl. glasnik RS, br. 22
Ministarstvo zdravlja Republike Srbije (2017-2018) Pravilnik o imunizaciji i načinu zaštite lekovima. Službeni glasnik RS, br. 88/17, 11/18, 14/18
Moss, W.J. (2017) Measles. Lancet, 390(10111): 2490-2502
Naim, Y.H. (2015) Measles virus: A pathogen, vaccine, and a vector. Hum Vaccin Immunother, 11(1): 21-26
o'Connor P., Jankovic, D., Muscat, M., Ben-Mamou, M., Reef, S., Papania, M., Singh, S., Kaloumenos, T., Butler, R., Datta, S. (2017) Measles and rubella elimination in the WHO Region for Europe: Progress and challenges. Clinical Microbiology and Infection, 23(8): 504-510
Palamara, M.A., Visalli, G., Picerno, I., di Pietro, A., Puglisi, G., Marano, F. (2018) Measles outbreak from February to August 2017 in Messina, Italy. J Prev Med Hyg, 59: E8-E13
Simons, E., Ferrari, M., Fricks, J., Wannemuehler, K., Anand, A., Burton, A., et al. (2012) Assessment of the 2010 global measles mortality reduction goal: Results from a model of surveillance data. Lancet, 9;379(9832):2173-78
Veličković, Z., Ilić, M., Rančić, N. (2016) Measles outbreak in the Nišava and Toplica districts. Acta medica Medianae, vol. 55, br. 2, str. 71-75
World Health Organization Immunization, Vaccines and Biologicals. Geneva, Switzerland, Available from: https://www.who.int/immunization/diseases/measles/en/[accessed 2019 January 25]
World Health Organization Vaccine-induced immunity appears to be long-term, and is probably lifelong in most individuals. Available from: https://measlesrubellainitiative.org/wp-content/uploads/2017/01/Surv-guidelines-measles-CR-infection.pdf [accessed 2019 January 27]
World Health Organization (WHO) (2018) Measles-containing vaccine 2nd dose: Reported estimates of MCV2 coverage. Geneva, [Internet]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragemcv2. html. [accessed 28 January 2019]
World Health Organization (WHO)- Regional Office for Europe (2014) Eliminating measles and rubella: Framework for the verification process in the WHO European Region 2014. Copenhagen, [accessed 28 January 2019]
World Health Organization (2018) Assessment report of the strategic global vaccine action plan. [accessed 28 January 2019]
World Health Organization (2012) Global measles and rubella strategic plan 2012-2020. Geneva, (http://apps.who.int/iris/bitstream/10665/44855/1/9789241503396_eng.pdf [accessed 28 January 2019]
World Health Organization (WHO) Vaccine-preventable diseases: Monitoring system: 2018 global summary. estimated vaccination coverage and VPD by country, Available from: http://apps.who.int/immunization_monitoring/globalsummary/countries?coun trycriteria%5bcountry%5d%5 b%5d=SRB [accessed 2019 January 2
 

About

article language: Serbian, English
document type: Original Paper
DOI: 10.5937/opmed1904080K
published in SCIndeks: 09/11/2019
Creative Commons License 4.0